Dri-Lyse Bacteriophage Technology (IUK 106291): Addressing the Challenges and Opportunities relating to COVID-19

Dri-Lyse 噬菌体技术 (IUK 106291):应对与 COVID-19 相关的挑战和机遇

基本信息

  • 批准号:
    10024565
  • 负责人:
  • 金额:
    $ 3.02万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

Bacterial pathogens of fresh produce are responsible for substantial losses through disease, damage and failure to meet market specifications, with no specific controls. Diseased crop and waste-food disposal, plus additional agricultural land and water required to achieve sufficient marketable yields all add up to increase the carbon footprint of food production ("foodprint") and more efficient agricultural systems, with less wastage are a priority to meet UK and EU targets of increased food productivity and reduced waste.**Bacteriophage** are viruses; they are the most abundant organisms on earth. As naturally-occurring bacterial enemies, they are attracting considerable attention as targeted agricultural antibacterial-control products. They are completely safe for the consumer, highly host-specific and have zero environmental or non-target impacts. APS Biocontrol has made good progress in demonstrating their potential in reducing bacterial plant disease but product commercial viability is limited; liquid products have limited thermal-stability, requiring low-temperature storage and transport, which impacts on their cost, shelf-life and storage. The project's **key objective** is to address these limitations, developing thermally-stable, dry bacteriophage products (_Dri-Lyse);_ achieved through working with Stabilitech BioPharma, an established UK developer of vaccines and therapeutics, with platform technologies to significantly enhance product stability, including for viruses and based around unique, safe, small molecules ("excipients") which are naturally present in foods. In pilot studies, their technology has given promising thermal stabilisation of sample bacteriophage, forming the background to this project.The project will focus on the UK and wider European potato market; through previous Innovate UK support APS has developed an effective bacteriophage mix ("BPSRE") against bacterial-induced "Blackleg" of potatoes, responsible for £50M UK total losses p.a. and £750M worldwide. APS has also developed a liquid bacteriophage product (Biolyse) to target the downstream losses caused by this disease; most frequently realised in the pack house as rotting potatoes. The focus of the **technical Innovation** will be creating an optimised excipient mix to maintain the activity of the BPSRE mix.Our vision is to switch from liquid bacteriophage mixes to a tableted/powered form, rehydratable at the point of use. Benefits will be a longer shelf life, making the products more manufacturable. Also, removing the need for chilled storage and transport, they become more attractive to the customer and significantly better placed to address export markets for business growth and globalisation. Once proven in the potato market, the longer vision is to address other high-value fresh-produce markets, both in the UK and globally.
新鲜农产品的细菌病原体由于疾病、损坏和不符合市场规格而造成重大损失,而没有具体的控制措施。减少作物和废弃食品的处理,加上实现足够的可销售产量所需的额外农业土地和水,所有这些都增加了粮食生产的碳足迹(“粮食足迹”)和更有效的农业系统,减少浪费是实现英国和欧盟提高粮食生产率和减少浪费的目标的优先事项。噬菌体 ** 是病毒;它们是地球上最丰富的生物。作为天然存在的细菌天敌,它们作为目标农业抗菌控制产品引起了相当大的关注。它们对消费者完全安全,高度宿主特异性,对环境或非目标影响为零。APS生物防治在证明其减少细菌性植物病害的潜力方面取得了良好进展,但产品的商业可行性有限;液体产品的热稳定性有限,需要低温储存和运输,这影响了其成本,保质期和储存。该项目的 ** 主要目标 ** 是解决这些限制,开发热稳定的干燥噬菌体产品(_Dri-Lyse);_通过与英国疫苗和治疗药物开发商Stabilitech BioPharma合作实现,该平台技术可显着提高产品稳定性,包括病毒和基于天然存在于食品中的独特,安全的小分子(“赋形剂”)。该项目将专注于英国和更广泛的欧洲马铃薯市场;通过之前的Innovate UK支持,APS已经开发出一种有效的噬菌体混合物(“BPSRE”),用于对抗细菌诱导的马铃薯“Blackleg”,每年造成5000万英镑的英国总损失。全球7.5亿英镑APS还开发了一种液体噬菌体产品(Biolyse),以针对这种疾病造成的下游损失;最常见的是在包装车间腐烂的土豆。** 技术创新 ** 的重点将是创造一种优化的赋形剂混合物,以保持BPSRE混合物的活性。我们的愿景是从液体噬菌体混合物转变为片剂/粉末形式,在使用时可再水化。好处将是更长的保质期,使产品更可制造。此外,消除了冷藏和运输的需求,它们对客户更具吸引力,并且更好地应对出口市场的业务增长和全球化。一旦在马铃薯市场得到证明,更长远的愿景是解决英国和全球其他高价值的新鲜农产品市场。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Studentship

相似海外基金

Dri-Lyse: Stabilised Bacteriophage Formulations for Sustainable Plant Protection and "Foodprint" Reduction
Dri-Lyse:用于可持续植物保护和减少“足迹”的稳定噬菌体配方
  • 批准号:
    48477
  • 财政年份:
    2020
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Study
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
利用纳米液滴技术提高难以裂解的微生物样品的诊断灵敏度
  • 批准号:
    10484601
  • 财政年份:
    2020
  • 资助金额:
    $ 3.02万
  • 项目类别:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
利用纳米液滴技术提高难以裂解的微生物样品的诊断灵敏度
  • 批准号:
    10081308
  • 财政年份:
    2020
  • 资助金额:
    $ 3.02万
  • 项目类别:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
利用纳米液滴技术提高难以裂解的微生物样品的诊断灵敏度
  • 批准号:
    10628013
  • 财政年份:
    2020
  • 资助金额:
    $ 3.02万
  • 项目类别:
Aufklärung des molekularen Mechanismus der Lyse autophagischer Vesikel im Innern der Vakuole von Saccharomyces cerevisiae
阐明酿酒酵母液泡内自噬囊泡裂解的分子机制
  • 批准号:
    5187902
  • 财政年份:
    1999
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了